Proteome profiling of diabetic mellitus patient urine for discovery of biomarkers by comprehensive MS-based proteomics

11Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Diabetic mellitus (DM) is a disease that affects glucose homeostasis and causes complications, such as diabetic nephropathy (DN). For early diagnosis of DN, microalbuminuria is currently one of the most frequently used biomarkers. However, more early diagnostic biomarkers are desired in addition to microalbuminuria. In this study, we performed comprehensive proteomics analysis of urine proteomes of diabetic mellitus patients without microalbuminuria and healthy volunteers to compare the protein profiles by mass spectrometry. With high confidence criteria, 942 proteins in healthy volunteer urine and 645 proteins in the DM patient urine were identified with label-free semi-quantitation, respectively. Gene ontology and pathway analysis were performed with the proteins, which were up- or down-regulated in the DM patient urine to elucidate significant changes in pathways. The discovery of a useful biomarker for early DN discovery is expected.

Author supplied keywords

Cite

CITATION STYLE

APA

Hirao, Y., Saito, S., Fujinaka, H., Miyazaki, S., Xu, B., Quadery, A. F., … Yamamoto, T. (2018). Proteome profiling of diabetic mellitus patient urine for discovery of biomarkers by comprehensive MS-based proteomics. Proteomes, 6(1). https://doi.org/10.3390/proteomes6010009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free